echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Tu Youyou team: Breakthrough in artemisinin resistance and new progress in the treatment of lupus erythematosus indications

    Tu Youyou team: Breakthrough in artemisinin resistance and new progress in the treatment of lupus erythematosus indications

    • Last Update: 2020-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On the evening of June 16, Xinhua put out a big suspense: according to Xinhua, Tu youyou's team will announce a major scientific breakthrough the next dayXinhua news agency client released the news with a video and a poem< br / > in the video, Tu Youyou, the Nobel Prize winner in physiology or medicine, said that once the malaria parasite becomes resistant to artemisinin combination therapy, there will be no cure for malaria, and human beings are bound to suffer a catastropheIn addition, Wang Jigang, a researcher at the artemisinin research center of the Chinese Academy of traditional Chinese medicine, said that without artemisinin, millions of people would die every year< br / > according to the report of Xinhua News Agency on June 17, Tu youyou and his team have made new breakthroughs in "malaria resistance mechanism research", "drug resistance causes", "adjustment of treatment methods" and other aspects after years of hard work in response to the "drug resistance" problem of artemisinin in some parts of the world in recent years, and put forward a practical treatment plan in the near future, New progress has been made in "artemisinin treatment of lupus erythematosus and other indications" and "traditional Chinese medicine research works going abroad", which have been highly recognized by the World Health Organization and authoritative experts at home and abroad< br / > under the influence of this news, artemisinin plate opened up sharply, kunyao group opened up one word trading limit, with more than 2 million sealed orders, Yuheng pharmaceutical industry trading limit, China Resources Shuanghe, XinHeCheng and Zhejiang Pharmaceutical Group opening high< br / > according to reports, after more than three years of scientific research, Tu youyou's team has made new breakthroughs in "malaria resistance mechanism research", "drug resistance causes", "adjustment of treatment methods", etc., and put forward new treatment response plans: first, appropriately extend the medication time, from three days to five or seven days; second, replace the adjuvant drugs that have developed resistance in artemisinin combination therapy, The effect is immediate< br / > according to the approval document for clinical trials of drugs issued by the State Drug Administration, the application for clinical trials of dihydroartemisinin tablets in the treatment of systemic lupus erythematosus and discoid systemic lupus erythematosus submitted by the Institute of traditional Chinese medicine of the Chinese Academy of Chinese medicine where Tu youyou's team is located has been approvedKunming Pharmaceutical Group Co., Ltdas the responsible unit to carry out clinical trials< br / > according to the Chinese Academy of traditional Chinese medicine, artemisinin and other traditional Chinese medicine research works written by Tu Youyou, researcher Liao Fulong of the Chinese Academy of traditional Chinese medicine and other experts are expected to be included in the international authoritative medical textbook Oxford medical textbook (6th Edition), which will be reprinted for the first timeThe industry believes that this will become an important practical achievement of "going out" of TCM culture.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.